bibliographicCitation |
Ding G, Wang J, Ding P, Wen Y, Yang L. Case report: HER2 amplification as a resistance mechanism to crizotinib in NSCLC with MET exon 14 skipping. Cancer Biology & Therapy. 2019 Feb 11;20(6):837–42. doi: 10.1080/15384047.2019.1566049. |